Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
link
Tags
biotech
clinical trials
life sciences
national blog main
alexion pharmaceuticals
alnylam
alnylam pharmaceutials
arena pharmaceuticals
arrowhead pharmaceuticals
artie suckow
boehringer ingelheim
boston
boston blog main
boston top stories
deals
dicerna pharmaceuticals
drug delivery
dtx pharma
eli lilly
financing
hepatitis b
indiana blog main
indiana top stories
jeff friedman
john grundy
johnson & johnson
national top stories
neurodegenerative diseases
primary hyperoxaluria
rna
rna interference
san diego
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
startups
tim scott
vc
wisconsin blog main
What
pharma
3
×
rna
3
×
medicines
new
small
abandoning
adapting
advance
ago
away
baggage
big
biologics
class
cofactor
companies
company
considered
consumer
cuts
deal
deliver
development
diagnostics
dicerna
discovery
diseases
drug
drugs
dtx
free
genomics
gets
hitting
interference
long
medical
molecules
nucleic
protecting
Language
unset
Current search:
pharma
×
rna
×
@xconomy.com
4 years ago
DTx Pharma Raises $10.6M to Advance New Way to Deliver RNA Drugs
@xconomy.com
5 years ago
Free of Baggage, Dicerna Cuts Another RNAi Deal and Gets $200M
@WIRED
8 years ago
Cofactor is an RNA sequencing company that's turning away from drug discovery for big pharma toward consumer diagnostics.